O especialista em testes de laboratório, BioGrad, anunciou planos para um crescimento adicional, pois expande suas operações para York. Esse investimento significativo acima de £ 3 milhões em 3 anos estabelecerá um novo local de pesquisa e ensino, posicionando a BioGRAD na vanguarda da ciência e da saúde, medicina regenerativa e pesquisa clínica.
O movimento da BioGrad para York é impulsionado pelas vantagens únicas da cidade, incluindo os pontos fortes acadêmicos e o potencial de colaboração com as universidades locais, a integração com o NHS Trusts em Yorkshire, e o apoio de York e a Autoridade de York para o North Yorkshire para a Autoridade Innovadora e a Autoridade de York e a Local de York e a Strateide, que servirá como um clínico de York, para o North Yorkshire, a Autoridade Innovadora. Anunciado no início de 2025.
This strategic location will serve as a catalyst for innovative research and a nation-wide clinical trial led by the York research team, anticipated to be announced early in 2025.
Este grupo BioGRAD já expandiu os serviços para 4 novos locais entre 2022-2024, incluindo laboratórios em Birmingham, Newcastle, Londres e um objetivo de pesquisa clínica construída e nova empresa sede no Wavertree Technology Park em Liverpool.
Continuing its expansion throughout the UK, BioGrad has also announced one new appointment in York and is actively recruiting to expand the team, growing its total headcount to 150 across the BioGrad Group.
BioGrad is leading the way in laboratory-based learning, diagnostics and most recently, advancements in women’s healthcare, with a clear mission that everyone should have access to gold standard healthcare and education. This latest development sees the company continue its nationwide expansion.
Dr Natalie Kenny, CEO, BioGrad, said:
“Our expansion into York represents an exciting new era for BioGrad as we expand our reach across the UK. The help and support BioGrad has received from Sophie Hartley, sector development relationship manager at York and North Yorkshire CA, and Christine Hogan, inward investment manager at City of York Council, and the York and North Yorkshire Combined Authority – as well as the strengths of the region in terms of its world-class NHS Trust and universities – makes York our preferred choice for expanding our operations and their assistance has been vital in enabling us to bring BioGrad’s offering and research capabilities to the city”.
“We take immense pride in our UK-wide presence and eagerly anticipate furthering our efforts to create new jobs and opportunities across the region.”
David Skaith, prefeito de York e North Yorkshire, disse:
“ É ótimo ver o especialista em testes de laboratório, BioGrad, mudar para York com um investimento de mais de 3 milhões de libras nos próximos três anos.
“Este investimento permitirá que o BioGRAD abra um novo local de pesquisa e ensino e crie empregos qualificados e de alta qualidade em um setor de alto crescimento.
“The demographic of our population, along with our excellent and growing number of research centres as well as our world-leading universities, we know we can be a major player in global healthcare and continue to go beyond expectation.”
For more information about BioGrad, visit the Site, X e Facebook.
